Transcriptome-Wide Analysis of Low-Concentration Exposure to Bisphenol A, S, and F in Prostate Cancer Cells

Area of Science:

• Endocrinology
• Molecular Biology
• Cancer Research

Background:

• Bisphenol A (BPA) is a widespread endocrine-disrupting chemical (EDC) linked to various diseases, including hormone-regulated cancers.
• BPA use is regulated globally, leading to the adoption of structural analogs like bisphenol S (BPS) and bisphenol F (BPF).
• The impact of BPA analogs on cancer progression, particularly prostate cancer (PCa), remains largely uncharacterized.

Purpose of the Study:

• To investigate the transcriptomic effects of low-dose exposure to BPA, BPS, and BPF on prostate cancer cell lines.
• To compare the molecular impact of these bisphenols across different stages of prostate cancer: androgen-dependent (LNCaP) and castration-resistant (PC-3).

Main Methods:

• Utilized an in vitro model system using LNCaP and PC-3 prostate cancer cell lines.
• Exposed cells to low concentrations of BPA, BPS, and BPF.
• Performed transcriptomic analysis to characterize the cellular response to each bisphenol exposure.

Main Results:

• Low-concentration exposure to BPA, BPS, and BPF induced differential transcriptomic effects in the two prostate cancer cell lines.
• Each bisphenol exhibited a unique molecular signature in response to exposure.
• The observed effects varied significantly between the androgen-dependent and castration-resistant PCa cell lines.

Conclusions:

• Bisphenol A structural analogs (BPS, BPF) exert distinct molecular effects on prostate cancer cells.
• The impact of endocrine-disrupting chemicals like bisphenols is stage-dependent in prostate cancer progression.
• Further research is crucial to understand the full implications of EDC exposure across all disease stages.